Patient support program

Once the clinical decision has been made to prescribe CAPLYTA

Support that helps your patients start and stay on treatment with confidence

CAPLYTA withMe makes it easy for your patients to receive access, affordability, and treatment support

Get streamlined prior authorization (PA) support through CAPLYTA withMe and CoverMyMeds®

For times when a PA may be required, CoverMyMeds® can help you navigate the electronic prior authorization (ePA) process

CoverMyMeds® helps link your office with payers to allow for electronic submission of PA requests and automation of the ePA process. It streamlines the access process for CAPLYTA

Prior Authorization
CAPLYTA® (lumateperone) savings card

CAPLYTA withMe
Savings Program

Eligible patients using commercial insurance can get up to a 90-day supply and may be able to:

  • Pay as little as $0 per month for CAPLYTA
  • Pay as little as $0 for a generic antidepressant

Maximum program benefit per calendar year shall apply. Offer subject to change or end without notice. Restrictions, including monthly maximums, may apply. See program requirements at CAPLYTAwithMeSavings.com.

Savings Card

CAPLYTA withMe
Trial Offer*

Start patients on CAPLYTA to see if it’s right for them.

Once prescribed, a trial offer is immediately available at no cost to eligible patients to help them become familiar with CAPLYTA. At the conclusion of the trial period, you and your patient decide whether to continue treatment.

Trial Offer

Three simple ways eligible patients can get a CAPLYTA withMe Savings Program Card

Patients can text CAPLYTA to 26789 to sign up for savings and refill reminders

Patients can download the Savings Program Card at CAPLYTA.com

You can provide your eligible patients with a hard copy of the Savings Program Card in your office

The patient support and resources provided by CAPLYTA withMe are not intended to give medical advice, replace a treatment plan from the patient’s healthcare provider, offer services that would normally be performed by the provider’s office, or serve as a reason to prescribe CAPLYTA.

*Subject to one (1) use per lifetime for the first 30-day supply of CAPLYTA. Terms expire at the end of each calendar year and may change. This Trial Offer is open to patients who have commercial insurance, government coverage, or no insurance coverage; however, there is no guarantee of continuous accessibility after the trial period ends. See program requirements at www.CAPLYTAwithMeTrialOffer.com

Message and data rates may apply. Message frequency varies. Text HELP for help. Text STOP to end. See Terms and Conditions and Privacy Statement.

Patients must be 18 years of age or older, residents of the U.S. or its territories, and have a valid prescription for CAPLYTA for an FDA-approved indication.